Skip to content

Newsroom

type
year
Illustration image.png

125,000 Orion Corporation A shares converted into B shares

10/7/2026 Stock exchange release
Illustration image.png

Orion Corporation completed share acquisitions

9/30/2026 Stock exchange release
Illustration image.png

Orion Corporation: Acquisition of own shares during week 40, 2026

9/30/2026 Stock exchange release
Illustration image.png

Orion Corporation: Acquisition of own shares during week 39, 2026

9/25/2026 Stock exchange release
Illustration image.png

Orion Corporation: Acquisition of own shares during week 38, 2026

9/18/2026 Stock exchange release
Illustration image.png

Orion Corporation: Acquisition of own shares during week 37, 2026

9/11/2026 Stock exchange release
Illustration image.png

Orion Corporation: Acquisition of own shares during week 36, 2026

9/4/2026 Stock exchange release
Illustration image.png

102,000 Orion Corporation A shares converted into B shares

9/4/2026 Stock exchange release
Illustration image.png

Orion Corporation to commence acquisition of own shares for its share-based incentive plans

8/27/2026 Stock exchange release
Illustration image.png

Orion’s license partner Tenax Therapeutics’ Phase 3 LEVEL trial of oral levosimendan in pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) did not reach its primary endpoint

8/10/2026 Stock exchange release
Illustration image.png

Orion Group Half-Year Financial Report January–June 2026

7/17/2026 Stock exchange release
Illustration image.png

Orion Corporation’s financial reporting and Annual General Meeting in 2027

7/17/2026 Stock exchange release
Illustration image.png

45,611 Orion Corporation A shares converted into B shares

7/15/2026 Stock exchange release
Illustration image.png

105,950 Orion Corporation A shares converted into B shares

5/15/2026 Stock exchange release
Illustration image.png

Composition of the Nomination Committee of Orion Corporation

4/27/2026 Stock exchange release
Illustration image.png

Orion Group Interim report January–March 2026

4/23/2026 Stock exchange release
Illustration image.png

Change in Orion Group Executive Team as of 8 April 2026 – Berkeley Vincent appointed Executive Vice President, Innovative Medicines

4/1/2026 Stock exchange release
Illustration image.png

Decisions taken by Orion Corporation's Annual General Meeting and Board of Directors' organising meeting on 24 March 2026

3/24/2026 Stock exchange release